The state has announced the launch of a "health survey" among the population living around the Lubrizol plant in Rouen. It must make it possible to "measure the nuisances that have been experienced by those exposed".

The state will conduct a "health survey" among the population that was under the smoke of the Lubrizol fire in Rouen, without taking blood samples immediately, which the party Europe Ecology Greens (EELV) finds "scandalous". "The objective of the declared general population health survey" which, in the field, is to start in March, is "to measure the nuisances that have been experienced by the people exposed, the symptoms felt, the impact on the quality of life, social relations, family, professional and then the psychosocial consequences and perceived health, "explained Anne Laporte, director of regions of the agency Public Health France at a committee on transparency on fire in Rouen .

215 municipalities concerned by the survey

This survey will concern the 215 municipalities that found themselves under the 22 km long smoke plume. Regarding the possible "biological survey", it will be based on samples. "It can be a collection of urine or blood.We are waiting for the analyzes and expertises on all that concerns the work on the environment to know if we will set up this biomonitoring survey, so I do not have any calendar for this investigation ", added Anne Laporte. It will not be "a survey on the general population but on sampling determined by the contaminated zones", she said.

>> READ ALSO: "Have real answers": near Lubrizol, the residents organize themselves in an association

The environmental survey aims to detect pollutants even at a "low and very low" dose, said Regional Environment Director Patrick Berg. "Today, the 150 samples taken are satisfactory," he added. Asked by AFP about the duration of the environmental survey, financed by Lubrizol and Normandie Logistique, he did not answer. The environmental survey, out of 215 municipalities, must be completed a priori in the coming months, told AFP Anne Laporte and the ARS.